Lt. Gutman et al., TUBERCULOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-EXPOSED OR VIRUS-INFECTED UNITED-STATES CHILDREN, The Pediatric infectious disease journal, 13(11), 1994, pp. 963-968
This study was designed to provide a preliminary assessment of the occ
urrence of tuberculosis exposure, infection and disease within a natio
nal sample of infants and children with human immunodeficiency virus (
HIV) exposure or infection, and to determine the prevalence of Mycobac
terium tuberculosis isolates resistant both to isoniazid and rifampin
in these patients or their adult source contacts. A retrospective ques
tionnaire survey was conducted of infants and children with HN exposur
e or infection evaluated by pediatric HIV referral centers in the Unit
ed States comprising the pediatric units or subunits of the Pediatric
Acquired Immunodeficiency Syndrome Clinical Trials Group (PACTG). Seve
nty of 72 sites during a mean period of 5 (range, 1 to 12) years parti
cipated in this study and had provided care for 14038 patients. There
were 75 cumulative total cases of tuberculosis disease seen since each
site was established. Therapy for asymptomatic infection was given to
another 40 children and for tuberculosis exposure to 71 children. Ann
ualized case rates mere 478/100000 for sites established in 1990 to 19
99, 117/100000 for 1988 to 1989, 63/100000 for 1986 to 1987 and 58/100
000 for 1981 to 1985 (P = 0.05, Spearman's p test for trend). By compa
rison, the 1992 age specific tuberculosis case rate for all U.S. child
ren < 5 years was 5.5/100000. Twenty percent of isolates from PACTG pa
tients and 15% of isolates from adult source contacts were resistant t
o isoniazid and rifampin. In children with HIV exposure or infection,
incident case rates of tuberculosis appear to exceed greatly those of
comparably aged children in the general population. Annualized case ra
tes increased progressively across PACTG sites of increasingly recent
establishment, possibly indicating that rates of infection increased o
ver time. Infection with and exposure to multiply drug-resistant strai
ns was common in PACTG patients. This study has identified the need to
monitor tuberculosis trends in HIV-exposed or -infected pediatric pat
ients, to determine the circumstances in which these children are expo
sed to tuberculosis, to identify opportunities to intervene and to int
egrate the needs of these children into national plans for tuberculosi
s control.